SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-218502
Filing Date
2022-08-11
Accepted
2022-08-11 16:02:17
Documents
14
Period of Report
2022-08-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d375990d8k.htm   iXBRL 8-K 25824
2 EX-99.1 d375990dex991.htm EX-99.1 77309
6 GRAPHIC g375990g0811085107368.jpg GRAPHIC 3975
  Complete submission text file 0001193125-22-218502.txt   244696

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sppi-20220811.xsd EX-101.SCH 2855
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sppi-20220811_lab.xml EX-101.LAB 18759
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sppi-20220811_pre.xml EX-101.PRE 11710
8 EXTRACTED XBRL INSTANCE DOCUMENT d375990d8k_htm.xml XML 3481
Mailing Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052
Business Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052 702-835-6300
SPECTRUM PHARMACEUTICALS INC (Filer) CIK: 0000831547 (see all company filings)

IRS No.: 930979187 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35006 | Film No.: 221155564
SIC: 2834 Pharmaceutical Preparations